1. Home
  2. Live Updates
  3. Lejla vajzovic

Live Breaking News & Updates on Lejla vajzovic

Stay informed with the latest breaking news from Lejla vajzovic on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Lejla vajzovic and stay connected to the pulse of your community

Duke Expert: Eye Protection Needed for Viewing Total Solar Eclipse

An estimated 31.6 million people live in the path of totality of the solar eclipse expected to pass over North America on April 8. As excitement builds, it&rsqu

Lejla-vajzovic , Leija-vajzovic , Duke-eye-center , Duke-university-school-of-medicine , Department-of-ophthalmology , North-america , Duke-university-school , Newswise , Clipse-eclipse-2024-eye-and-vision-total-solar-retina-burns , Uke-health ,

Ocugen, Inc. Announces Dosing Completion of Subjects with Geographic Atrophy in Cohort 1 of Phase 1/2 Clinical Trial Evaluating the Safety and Efficacy of OCU410

MALVERN, Pa., March 13, 2024 -- Ocugen, Inc. , a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that...

United-states , American , Americans , Neena-haider , Lejla-vajzovic , Matthew-levine , Shankar-musunuri , Exchange-commission , Ocugen-inc , American-macular-degeneration-foundation , Duke-university-eye-center , Linkedin

Ocugen Clinical Showcase Webcast Now Available

Ocugen Clinical Showcase Webcast Now Available
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Lejla-vajzovic , Neena-haider , Harvard-medical-school , Ocugen-inc , Head-of-communications , Exchange-commission , Duke-university-school-of-medicine , University-of-miami , Clinical-showcase , Byron-lam , Endowed-chair

Ocugen to Host Clinical Showcase in New York City

Highlighting updates on OCU400 Phase 3 clinical trial starting early 2024 Featuring thought leaders in gene therapy and OCU400 Phase 1/2 clinical trial...

New-york , United-states , Times-square , Lejla-vajzovic , Arun-upadhyay , Neena-haider , Shankar-musunuri , Harvard-medical-school , Head-of-communications , Duke-university-school-of-medicine , University-of-miami , Ocugen-inc

Ocugen to Host Clinical Showcase in New York City on Wednesday, February 21, 2024

Ocugen to Host Clinical Showcase in New York City on Wednesday, February 21, 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New-york , United-states , Times-square , Neena-haider , Arun-upadhyay , Lejla-vajzovic , Shankar-musunuri , Nasdaq , Exchange-commission , Tiffany-hamiltonhead-of-communications , Ocugen-inc , Linkedin

Ocugen to Host Clinical Showcase in New York City on Wednesday, February 21, 2024

Ocugen to Host Clinical Showcase in New York City on Wednesday, February 21, 2024
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

New-york , United-states , Times-square , Lejla-vajzovic , Neena-haider , Arun-upadhyay , Shankar-musunuri , Duke-university-school-of-medicine , Nasdaq , Harvard-medical-school , University-of-miami , Ocugen-inc

One-year trial outcomes demonstrate efficacy of ABBV-RGX-314 gene therapy for DR

One-year trial outcomes demonstrate efficacy of ABBV-RGX-314 gene therapy for DR
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Lejla-vajzovic ,

OCUGEN ANNOUNCES POSITIVE CLINICAL STUDY UPDATE FROM THE PHASE 1/2 TRIAL OF OCU400, A MODIFIER GENE THERAPY PRODUCT CANDIDATE, FOR THE TREATMENT OF RETINITIS PIGMENTOSA AND LEBER CONGENITAL AMAUROSIS

MALVERN - Ocugen, Inc. , a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today announced a clinical study...

Los-angeles , California , United-states , Arun-upadhyay , Lejla-vajzovic , David-boyer , Shankar-musunuri , Duke-vitreoretinal-fellowship-program , Duke-eye-center , Retina-vitreous-associates-medical-group , Keck-school-of-medicine-los-angeles , Head-of-research

Ocugen to Host Virtual Investor & Analyst Event on September 13, 2023

Ocugen to Host Virtual Investor & Analyst Event on September 13, 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Shankar-musunuri , Lejla-vajzovic , Arun-upadhyay , Duke-university-school-of-medicine , Ocugen-inc , University-of-miami , Head-of-clinical-development , Linkedin , Head-of-communications , Head-of-research , Bascom-palmer-eye-institute

Ocugen to Host Virtual Investor & Analyst Event on

Company to share updated results from ongoing Phase 1/2 trial of OCU400 for the treatment of Retinitis Pigmentosa and Leber Congenital Amaurosis...

Lejla-vajzovic , Arun-upadhyay , Shankar-musunuri , Ocugen-inc , Exchange-commission , University-of-miami , Twitter , Head-of-communications , Head-of-research , Linkedin , Duke-university-school-of-medicine